Bio Preventive Medicine Corp.

DNlite-IVD103 is a patented and clinically validated non-invasive ELISA testing kit which can predict renal function loss years in advance. It\\\'s a true gold standard for Diabetic Kidney Disease Management, and can be used as an aid in kidney function accessement for kidney transplant recipients.

BIOCARE TECHNOLOGY CO., LTD.

Biomdcare

Biomedica - Smart Osteoporosis Screening Solution developed can perform osteoporosis risk analysis on X-ray images and generate customized reports within 6 seconds, addressing the challenges of conventional X-ray testing methods. With up to 90% accuracy in osteoporosis detection, this solution can assist physicians in interpreting X-ray images and provide diagnostic recommendations. Therefore, this AI technology has the potential to become a powerful tool for early disease prevention and screening.

Biomedical EliteCell Corp.

With 10-years experiences, EliteCell aims to providing optimal cell culture solutions for a broad range of cells to support and accelerate the development of cell therapies and regenerative medicines from research to clinic.

EliteCell's cGMP-compliant facility located in Texas, USA. EliteCell supplies xenogeneic-free serum replacement, serum-free human lymphocytes culture media, primary NK culture kit to the top research and academic institutions as well as biotechnology, cell therapy, and pharmaceutical companies in worldwide.

bioMerieux

A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries through a large network of distributors. bioMérieux provides diagnostic solutions (systems, reagents, software, and services) that determine the origin of a disease to improve the health of patients. World leader in microbiology, specialized in immunoassays and leading pioneer in the syndromic molecular approach, the Company is committed worldwide on major public health issues in the field of infectious diseases, such as antimicrobial resistance, sepsis and respiratory infections.

BIONET Corp.

BIONET is the first publicly listed company in Taiwan specializing in cell therapy that possesses the core technology and preparation capabilities of medical-grade cell therapy products. The company not only applies cells to more than 60 types of diseases but also provides exosome services. In addition, The Mesenchymal Stem Cell bank was established in 2005. Under the special regulations for cell therapy by the Ministry of Health and Welfare, approved treatments include the use of adipose-derived stem cells for osteoarthritis and chronic wounds, and immune cells (CIK) for the treatment of various cancers such as colorectal cancer, lung cancer, breast cancer, and liver cancer.

BIONET Corp.

BIONET is the first publicly listed company in Taiwan specializing in cell therapy that possesses the core technology and preparation capabilities of medical-grade cell therapy products. The company not only applies cells to more than 60 types of diseases but also provides exosome services. In addition, The Mesenchymal Stem Cell bank was established in 2005. Under the special regulations for cell therapy by the Ministry of Health and Welfare, approved treatments include the use of adipose-derived stem cells for osteoarthritis and chronic wounds, and immune cells (CIK) for the treatment of various cancers such as colorectal cancer, lung cancer, breast cancer, and liver cancer.

Bionime

Bionime—a total solution provider in glucose monitoring system with 20 years manufacture experience.

*We provide one stop solution from patient to market:
Our patient centered ecosystem for diabetes care connects all medical things and the market via IoT technology. We create an ecosystem includes self-monitoring devices (CGM, BGM), remote diabetes management system(DMS), circle of support(Care app), healthcare facilities and online service.

*We are 100% in-house manufacturer:
Experienced in product development and
manufacturing. Comprehensive technologies are highly integrated into our manufacturing process.

*Toward industry 4.0 :
Self-developed automatic production equipment could attain intelligent production goal.

BiOptic Inc.

BiOptic is a capillary electrophoresis related manufacturer in Asia. We provide global users with one-stop solutions from sample preparation, gene amplification to fragment analysis. The opening platform can be applied to any biotechnology research, genetic testing, clinical diagnosis and other related fields.

Three steps to finish your test, simple and easy:
Step1. Sample Preparation: Qexp Series Detection Kit
Step2. Gene Amplification: Qampmini Thermal Cycler
Step3. Fragment Analysis: Qsep Series Bio-Fragment Analyzer

BIOTOOLS CO., LTD

BIOTOOLS, established in 2012, has been guided by the core principle of "We accompany scientists in their continuous advancement, providing the best solutions for scientific research, and creating infinite value for science." Scientists in the field of life sciences require various biological technologies to conduct relevant experiments and research. We provide corresponding products and technologies to ensure that scientists from both academia and industry can smoothly navigate all aspects, from experimentation to application.

In the field of life sciences, with a focus on the research needs surrounding extracellular vesicles, we have integrated products and services from Hansa BioMed and Croyez Bioscience to offer our customers an all-encompassing solution for extracellular vesicle integration analysis. This solution includes separation reagent sets for extracellular vesicles of different sizes, characterization, quality control (QC), high-throughput analysis of contents (such as proteomics, single extracellular vesicle analysis, RT-PCR for miRNA, etc.).

In the realm of gene sequencing services, BIOTOOLS also provides the latest third-generation sequencing technology, applicable to various species' genome research, cancer gene testing, and the "Microbial Identification" application, which our company is particularly focused on.

Through our experience in microbial sequencing over the years, we have identified persistent challenges in clinical medicine regarding microbial identification. In 2020, we founded Asia Pathogenomics Co., Ltd. to address these challenges. Leveraging mNGS (metagenomic next-generation sequencing) technology, we offer comprehensive, precise, and rapid detection of pathogens within patient samples.

At BIOTOOLS, we are committed to advancing scientific research and providing cutting-edge solutions in the field of life sciences. We look forward to the opportunity to collaborate and contribute to the scientific community at the upcoming medical-related exhibition.